Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 81-90 of 180 for melanoma

Edit search filters
  1. An Investigational Immuno-therapy Study To Assess The Safety, Tolerability And Effectiveness Of Anti-LAG-3 With And Without Anti-PD-1 In The Treatment Of Solid Tumors

    Rochester, MN

  2. MART-1 Antigen With Or Without TLR4 Agonist GLA-SE In Treating Patients With Stage II-IV Melanoma That Has Been Removed By Surgery

    Rochester, MN

  3. Study To Compare Adjuvant Immunotherapy Of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection Of Melanoma In Patients At High Risk For Recurrence

    Rochester, MN

  4. A Study Comparing A Vaccine With Or Without An Autologous Tumor Lysate To Treat Stage III Or IV Melanoma To Prevent Recurrence

    Scottsdale/Phoenix, AZ, Rochester, MN

  5. Program For Pembrolizumab (MK-3475) In Participants With Metastatic Melanoma Who Have Failed Standard Of Care Therapy Including Ipilimumab (MK-3475-030)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  6. A Study To Evaluate A Standard-dose And High- Dose Regimen Of Encorafenib + Binimetinib In Patients With BRAFV600-mutant Melanoma Brain Metastasis

    Rochester, MN

  7. Study Of Pembrolizumab (MK-3475) In Participants With Progressive Locally Advanced Or Metastatic Carcinoma, Melanoma, Or Non-small Cell Lung Carcinoma (P07990/MK-3475-001/KEYNOTE-001)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  8. Paclitaxel Albumin-Stabilized Nanoparticle Formulation And Bevacizumab Or Ipilimumab As First-Line Therapy In Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery

    Scottsdale/Phoenix, AZ, Rochester, MN

  9. Gemini Study To Evaluate The Integration Of Cancer Genetic Testing Into A Cancer Clinical Practice At Mayo Clinic At Arizona

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  10. An Investigational Immuno-therapy Study Of Nivolumab Combined With Ipilimumab Compared To Nivolumab By Itself After Complete Surgical Removal Of Stage IIIb/c/d Or Stage IV Melanoma

    Rochester, MN

.

Mayo Clinic Footer